GO:0140942 histone H3K9 dimethyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140942 describes the enzymatic activity that successively adds two methyl groups to lysine 9 of histone H3, producing the repressive mark H3K9me2.
• The principal enzymes carrying this activity are G9a (EHMT2) and GLP (EHMT1), which often function as a heteromeric complex.
• H3K9me2 is a hallmark of facultative heterochromatin and is associated with transcriptional silencing.
• G9a/GLP-mediated H3K9me2 regulates diverse processes including memory consolidation, adipocyte differentiation, plasma cell differentiation, and innate immune memory.
• Dysregulation of H3K9me2 is implicated in cancer, neurodegeneration, and substance use disorders.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential for dissecting the causal roles of H3K9 dimethyltransferases.
Description
Histone H3K9 dimethyltransferase activity (GO:0140942) is a molecular function that catalyzes the addition of two methyl groups to the lysine residue at position 9 of histone H3, yielding the dimethylated mark H3K9me2. This modification is a key epigenetic signal for transcriptional repression and heterochromatin formation. The enzymes responsible for this activity, notably G9a (EHMT2) and GLP (EHMT1), are essential for various developmental and physiological processes. Understanding GO:0140942 is crucial for researchers studying gene regulation, chromatin dynamics, and diseases linked to epigenetic dysregulation. This article provides a comprehensive overview of the mechanism, key genes, and research methods associated with this activity.
histone H3K9 dimethyltransferase activity At A Glance
| GO ID | GO:0140942 |
|---|---|
| GO term | histone H3K9 dimethyltransferase activity |
| Ontology | molecular_function |
| Synonym | histone H3K9 dimethylase activity, histone H3-K9 dimethylation, histone H3K9 dimethylation, histone H3K9 mono/dimethylase activity, histone lysine N-dimethyltransferase activity (H3-K9 specific) |
| Major function | Catalyzes the dimethylation of histone H3 at lysine 9, leading to transcriptional repression |
| EC number | 2.1.1.43 (histone-lysine N-methyltransferase) |
| Substrates | L-lysyl9-[histone H3], S-adenosyl-L-methionine |
| Products | N6,N6-dimethyl-L-lysyl9-[histone H3], S-adenosyl-L-homocysteine, H+ |
What Is GO:0140942?
GO:0140942 is defined as the catalysis of the reaction: L-lysyl9-[histone H3] + 2 S-adenosyl-L-methionine = 2 H+ + N6,N6-dimethyl-L-lysyl9-[histone H3] + 2 S-adenosyl-L-homocysteine. In simpler terms, it is the enzyme activity that adds two methyl groups to the ninth lysine of histone H3, producing H3K9me2.
Why Is histone H3K9 dimethyltransferase activity Important in Cell Biology?
Histone H3K9 dimethyltransferase activity is central to epigenetic regulation, as H3K9me2 serves as a docking site for heterochromatin protein 1 (HP1) and other repressive factors, leading to chromatin compaction and gene silencing. This activity is critical for normal development, cellular differentiation, and memory formation. Its dysregulation has been linked to cancer, neurodegenerative disorders, and addiction, making it a potential therapeutic target.
• Regulates gene expression through heterochromatin formation.
• Essential for long-term spatial memory consolidation.
• Controls adipocyte differentiation and thermogenic gene programming.
• Modulates innate immune memory in macrophages.
• Involved in plasma cell differentiation.
• Implicated in ethanol-induced neurodegeneration.
• Associated with cocaine self-administration and anxiety.
• Plays a role in cellular senescence via DNA damage signaling.
• Potential target for cancer therapy.
• Key for understanding epigenetic inheritance.
What Happens During histone H3K9 dimethyltransferase activity?
Substrate Recognition and Binding
In simple terms: The enzyme finds and attaches to the histone protein.
The enzyme recognizes the N-terminal tail of histone H3, specifically the lysine 9 residue, through its catalytic SET domain. This binding is often facilitated by accessory proteins within the G9a/GLP complex.
Methyl Group Transfer
In simple terms: The enzyme adds two methyl groups to the lysine.
Using S-adenosyl-L-methionine (SAM) as the methyl donor, the enzyme catalyzes two successive methylation reactions, first converting H3K9me0 to H3K9me1, then to H3K9me2. This stepwise addition is processive and requires the cofactor SAM.
Product Release and Chromatin Modification
In simple terms: The modified histone is released, leading to gene silencing.
After dimethylation, the H3K9me2 mark is recognized by HP1 proteins, which promote chromatin compaction and transcriptional repression. The enzyme releases the product and S-adenosyl-L-homocysteine (SAH).
Key Genes Involved in GO:0140942 histone H3K9 dimethyltransferase activity
The following genes encode proteins with histone H3K9 dimethyltransferase activity or are closely associated with its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EHMT2 (G9a) | Histone H3K9 dimethyltransferase | Primary enzyme for H3K9me2; involved in memory, addiction, cancer |
| EHMT1 (GLP) | Histone H3K9 dimethyltransferase | Forms heteromeric complex with G9a; essential for development |
| ATF7 | Transcription factor | Recruits G9a to target genes; mediates innate immune memory |
| FOXO1 | Transcription factor | Interacts with G9a in plasma cell differentiation |
| ETS1 | Transcription factor | Interacts with G9a in plasma cell differentiation |
| CDH1 | Cell cycle regulator | Triggers degradation of histone methyltransferases in senescence |
| PKA | Protein kinase | Accelerates early differentiation of pluripotent stem cells |
| HP1 | Heterochromatin protein | Binds H3K9me2 and mediates gene silencing |
| SUV39H1 | Histone H3K9 methyltransferase | Catalyzes H3K9me3, a related mark |
| SETDB1 | Histone H3K9 methyltransferase | Catalyzes H3K9me3, involved in gene silencing |
| KDM3A | Histone demethylase | Removes methyl groups from H3K9me1/2 |
| KDM4C | Histone demethylase | Removes methyl groups from H3K9me2/3 |
| DNMT1 | DNA methyltransferase | Cooperates with H3K9me2 in heterochromatin |
| DNMT3A | DNA methyltransferase | Cooperates with H3K9me2 in heterochromatin |
| HDAC1 | Histone deacetylase | Part of repressive complexes with G9a |
| HDAC2 | Histone deacetylase | Part of repressive complexes with G9a |
| MECP2 | Methyl-CpG-binding protein | Binds methylated DNA and recruits H3K9 methyltransferases |
How Is histone H3K9 dimethyltransferase activity Regulated?
Histone H3K9 dimethyltransferase activity is regulated at multiple levels. The G9a/GLP complex can be recruited to target genes by transcription factors such as ATF7 and FOXO1/ETS1. Its activity is also controlled by post-translational modifications and interaction with other chromatin-modifying enzymes. For example, protein kinase A (PKA) signaling accelerates early differentiation of pluripotent stem cells, potentially influencing H3K9 methylation dynamics. Additionally, DNA damage signaling triggers degradation of histone methyltransferases through the APC/C-Cdh1 pathway in senescent cells, reducing H3K9me2 levels.
histone H3K9 dimethyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EHMT2 (G9a) | Cocaine addiction, anxiety | Overexpression in nucleus accumbens shell of mice |
| EHMT2 (G9a) | Ethanol-induced neurodegeneration | Knockout or pharmacological inhibition in neonatal mice |
| EHMT2 (G9a) | Plasma cell differentiation | Knockout in B cells |
| ATF7 | Innate immune memory | Knockout in macrophages |
| EHMT2 (G9a) | Spatial memory consolidation | Knockout in mouse brain |
Cancer
Overexpression of G9a and elevated H3K9me2 levels are observed in various cancers, where they silence tumor suppressor genes and promote proliferation. Targeting G9a activity is being explored as a therapeutic strategy.
Neurodegeneration and Addiction
G9a-mediated H3K9me2 in the nucleus accumbens shell is linked to cocaine self-administration, stress-induced reinstatement, and anxiety-like behaviors. In neonatal mouse brain, G9a activity regulates ethanol-induced neurodegeneration.
Immune Disorders
ATF7-dependent recruitment of G9a mediates lipopolysaccharide-induced epigenetic changes in macrophages, contributing to innate immune memory. G9a also controls plasma cell differentiation through FOXO1 and ETS1 binding site regulatory networks.
From histone H3K9 dimethyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does G9a overexpression affect cocaine reward? | Overexpression of G9a in nucleus accumbens shell |
| Is G9a required for spatial memory? | Conditional knockout in mouse forebrain |
| How does ATF7 regulate innate immune memory? | ATF7 knockout macrophages |
| What is the role of G9a in plasma cell differentiation? | B cell-specific G9a knockout |
| Does PKA signaling influence H3K9 methylation during differentiation? | PKA activation in pluripotent stem cells |
| How does DNA damage affect H3K9 methyltransferase stability? | Senescent cells with APC/C-Cdh1 knockdown |
How to Study the histone H3K9 dimethyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ChIP-seq | Genome-wide distribution of H3K9me2 | Mapping heterochromatin domains |
| Western blot | Global H3K9me2 levels | Validating knockout or inhibitor effects |
| RNA-seq | Transcriptional changes | Identifying genes silenced by H3K9me2 |
| Co-immunoprecipitation | Protein-protein interactions | Studying G9a/GLP complex formation |
| Mass spectrometry | Histone modification quantification | Detecting H3K9me2 stoichiometry |
| Behavioral assays | Addiction, memory, anxiety | Linking H3K9me2 to behavior |
| CRISPR screens | Functional genomics | Identifying modifiers of H3K9me2 |
Chromatin Immunoprecipitation (ChIP)
ChIP with antibodies against H3K9me2 or G9a is used to map the genomic distribution of this mark and its writer enzymes.
Western Blotting
Western blot analysis with H3K9me2-specific antibodies quantifies global changes in dimethylation levels upon genetic or pharmacological manipulation.
RNA Sequencing (RNA-seq)
RNA-seq reveals transcriptional changes following knockout or overexpression of H3K9 dimethyltransferases, identifying target genes and pathways.
Behavioral Assays
Behavioral tests such as cocaine self-administration and spatial memory tasks assess the functional consequences of manipulating H3K9me2 in vivo.
How CRISPR Can Be Used to Study GO:0140942 histone H3K9 dimethyltransferase activity
Knockout
CRISPR knockout of EHMT2 or EHMT1 eliminates H3K9 dimethyltransferase activity, enabling studies of loss-of-function phenotypes in development, memory, and immunity.
Point Mutation
Introducing point mutations in the catalytic SET domain of G9a can abolish enzymatic activity while preserving protein interactions, helping dissect catalytic versus scaffolding functions.
Knock-in
Knock-in of tagged G9a (e.g., HA or GFP) allows for ChIP-seq and proteomic studies to map its genomic binding sites and interacting partners.
Overexpression
Overexpression of G9a in specific brain regions or cell types can model gain-of-function states observed in addiction and cancer.
How EDITGENE Supports histone H3K9 dimethyltransferase activity Research
Researchers studying histone H3K9 dimethyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for histone H3K9 dimethyltransferase activity research.
Frequently Asked Questions About histone H3K9 dimethyltransferase activity
What is histone H3K9 dimethyltransferase activity?
It is the enzyme activity that adds two methyl groups to lysine 9 of histone H3, producing H3K9me2, a repressive epigenetic mark.
What genes are involved in histone H3K9 dimethyltransferase activity?
The main genes are EHMT2 (G9a) and EHMT1 (GLP), which encode the enzymes responsible for this activity.
What is the role of H3K9me2 in gene expression?
H3K9me2 is associated with transcriptional silencing and heterochromatin formation.
How is histone H3K9 dimethyltransferase activity regulated?
It is regulated by recruitment via transcription factors like ATF7, and by post-translational modifications and degradation pathways.
What diseases are linked to H3K9me2 dysregulation?
Cancer, neurodegeneration, addiction, and immune disorders have been linked to altered H3K9me2 levels.
What methods are used to study histone H3K9 dimethyltransferase activity?
ChIP-seq, Western blot, RNA-seq, and behavioral assays are commonly used.
Can CRISPR be used to study H3K9 dimethyltransferase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools for dissecting its functions.
What is the difference between H3K9me2 and H3K9me3?
H3K9me2 is dimethylation, while H3K9me3 is trimethylation; both are repressive marks but are deposited by different enzymes.
Which enzyme complex is responsible for H3K9me2?
The G9a/GLP heteromeric complex is the major enzyme complex for H3K9me2.
How does H3K9me2 affect memory?
G9a/GLP activity is required for long-term consolidation of spatial memory in mice.
Conclusion
Histone H3K9 dimethyltransferase activity (GO:0140942) is a fundamental epigenetic mechanism that controls gene silencing and chromatin architecture. Its dysregulation contributes to a wide range of diseases, from cancer to addiction. Continued research using advanced CRISPR models and genomic technologies will further illuminate its roles and therapeutic potential.
References
- 1. Anderson EM et al.. 2018. Overexpression of the Histone Dimethyltransferase G9a in Nucleus Accumbens Shell Increases Cocaine Self-Administration, Stress-Induced Reinstatement, and Anxiety.. J Neurosci 38(4):803-813 PMID: 29217682
- 2. George-Alexander LMM et al.. 2025. G9a controls plasma cell differentiation through FOXO1 and ETS1 binding site regulatory networks.. J Immunol 214(9):2408-2424 PMID: 40581629
- 3. Nicolay-Kritter K et al.. 2021. The histone H3 lysine 9 methyltransferase G9a/GLP complex activity is required for long-term consolidation of spatial memory in mice.. Neurobiol Learn Mem 179:107406 PMID: 33609736
- 4. Minakawa T et al.. 2020. Protein kinase A accelerates the rate of early stage differentiation of pluripotent stem cells.. Biochem Biophys Res Commun 524(1):57-63 PMID: 31980180
- 5. Subbanna S et al.. 2013. G9a-mediated histone methylation regulates ethanol-induced neurodegeneration in the neonatal mouse brain.. Neurobiol Dis 54:475-85 PMID: 23396011
- 6. Liu Y et al.. 2019. The Transcription Factor ATF7 Controls Adipocyte Differentiation and Thermogenic Gene Programming.. iScience 13:98-112 PMID: 30826729
- 7. Yoshida K et al.. 2015. The transcription factor ATF7 mediates lipopolysaccharide-induced epigenetic changes in macrophages involved in innate immunological memory.. Nat Immunol 16(10):1034-43 PMID: 26322480
- 8. Takahashi A et al.. 2012. DNA damage signaling triggers degradation of histone methyltransferases through APC/C(Cdh1) in senescent cells.. Mol Cell 45(1):123-31 PMID: 22178396
